Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics with Late-Onset Sepsis

Trial Identifier: D3720C00009
Sponsor: AstraZeneca
Collaborator:
PRA Health Sciences
NCTID:: NCT02424734
Start Date: August 2015
Primary Completion Date: October 2017
Study Completion Date: October 2017
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Hungary Budapest, Hungary, 1125
Hungary Budapest, Hungary, 1131
Hungary Budapest, Hungary, 1097
Hungary Gyula, Hungary, 5700
Hungary Nyíregyháza, Hungary, 4400
Hungary Pécs, Hungary, 7623
Hungary Szeged, Hungary, 6720
Hungary Szekszárd, Hungary, 7100
Hungary Szombathely, Hungary, 9700
Italy Milano, Italy, 20122
Italy Verona, Italy, 37126
Lithuania Vilnius, Lithuania, LT-08406
United States of America, CA Los Angeles, CA, United States of America, 90033
United States of America, California San Diego, California, United States of America, 92123
United States of America, GA Augusta, GA, United States of America, 30912-0012
United States of America, IL Springfield, IL, United States of America, 62701
United States of America, LA Shreveport, LA, United States of America, 71103
United States of America, NY Brooklyn, NY, United States of America, 11203
United States of America, OH Dayton, OH, United States of America, 45404-1815
United States of America, OH Toledo, OH, United States of America, 43606
United States of America, TX Austin, TX, United States of America, 78723
United States of America, VA Richmond, VA, United States of America, 23298